Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatropin in SGA Children
NCT00184717Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2004
- Primary completion
- Mar 2006
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of somatropin in short stature (5 arms), sponsored by Novo Nordisk. Primary endpoint: Change in Height Standard Deviation Score (SDS) for Chronological Age (CA) at 208 weeks. Started Aug 2004; status: completed.
02
Drugs
somatropin
03
Conditions
short stature
Beyond the preview
Go deeper on NCT00184717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00184717.